We present the first reported case involving the peripartum anaesthetic management of dopamine beta-hydroxylase deficiency in a 22-year-old primigravida with high-grade placenta praevia. Elective caesarean section was performed at 36 weeks gestation with a combined spinal-epidural regional anaesthetic technique. Extensive preparation was undertaken to manage the consequences of obstetric haemorrhage and consideration given to potential pharmacological sensitivities suspected to exist in patients with this rare disorder affecting sympathetic nervous system function. An uncomplicated caesarean section was performed from which the patient recovered well to be discharged home with a healthy baby.
Dopamine beta-hydroxylase (DBH) is the enzyme that catalyzes the conversion of dopamine to noradrenaline 1 . Congenital absence or deficiency of this enzyme is an extremely rare condition. Amongst other manifestations (see Table 1 ), patients with this disorder invariably have severe orthostatic hypotension. DBH deficient patients are difficult to treat using standard therapeutic approaches for autonomic failure. The use of the amino acid dihydrophenylserine (DOPS) has resulted in dramatic increases in blood pressure and restoration of plasma and urinary levels of noradrenaline towards normal 3 . The proposed action of DOPS is through its peripheral conversion, by dopa-decarboxylase, to noradrenaline.
We believe that this is the first published report describing the peripartum anaesthetic management of a patient with DBH deficiency. The management of our patient was made more interesting by coexisting high-grade placenta praevia demanding a preterm caesarean section.
CASE HISTORY
A 22-year-old primigravida at 29 weeks gestation with high-grade placenta praevia and DBH deficiency was referred to our department for early assessment regarding her peripartum management. DBH deficiency had been diagnosed at age 14 years after a six-year history of postural syncope and exercise intolerance. She had been well treated on DOPS with good symptom control until the time of the pregnancy. During the first two trimesters of the pregnancy she suffered increasing postural symptoms requiring dose escalation of DOPS with little improvement. Despite a supine BP of 95/60 mmHg and a sitting BP of 80/40 mmHg the foetus appeared to be developing normally with no evidence of intrauterine growth retardation. In addition to hypotension, our patient also had other features often seen in DBH deficient patients including ptosis and hypermobile joints. The managing obstetric team proposed an operative delivery by caesarean section. The decision regarding the timing of the delivery was made in consultation with the departments of anaesthesia and neonatal medicine. Taking into consideration the risks of antepartum haemorrhage, emergency caesarean section and general anaesthesia versus those of foetal immaturity, elective caesarean section was scheduled for 36 weeks gestation.
On the day of surgery the patient received 100 mg of DOPS at 0600 h and 1100 h with surgery planned for 1300 h. In addition, she was also given routine antacid prophylaxis just prior to transfer to the operating room.
In the anaesthetic room, intravenous access was secured with two 14 gauge peripheral cannulae, one of which was attached to a primed rapid infusion device. Invasive pressure monitoring was established after the insertion of a 20 gauge radial arterial line and a right internal jugular central venous line. After a one litre crystalloid fluid bolus the patient was transferred to the operating room and positioned in the left lateral position for the combined spinal-epidural. Baseline observations showed heart rate (HR) 78 bpm, mean arterial pressure (MAP) 77 mmHg (110/60 mmHg), and central venous pressure (CVP) 8 mmHg.
In the lateral position an uncomplicated combined spinal-epidural was performed and an intrathecal dose of 5 mg hyperbaric bupivacaine and 15 µg fentanyl produced a sensory block to T8. The patient was then placed in the supine position with left uterine displacement and an epidural dose of 0.75% ropivacaine 5 ml was injected and resulted in a sensory block to T2. Over the 20 minutes required to acquire satisfactory surgical anaesthesia the HR and MAP remained stable, 70 to 80 bpm and 80 to 85 mmHg respectively, however, the CVP fell from 8 to 3 mmHg. The patient's legs were then put into the adjustable hydraulic stirrups and elevated 10 degrees with a resultant increase in MAP to 100 mmHg and CVP to 10 mmHg.
Caesarean section was then performed resulting in the uncomplicated delivery of a healthy and active male infant. After the umbilical cord was clamped, intravenous oxytocin 10 units was administered incrementally over eight minutes. This and blood loss of approximately 400 ml resulted in the MAP and CVP falling from 100 to 60 mmHg and 10 to 4 mmHg, respectively. Haemodynamics responded rapidly to intravenous crystalloid and no vasopressors were required.
The postoperative course was uncomplicated. An epidural pethidine infusion was used for the first 48 h and then replaced by oral paracetamol and oxycodone. Haemodynamics in the postoperative period rapidly returned from the higher pressures seen intraoperatively to those measured preoperatively with MAP 65 mmHg. Mother and baby were discharged home on day 7 in good condition.
DISCUSSION
DBH deficiency is an extremely rare congenital cause of dysautonomia characterized by noradrenergic denervation and adrenomedullary failure, but intact baroreflex afferents, cholinergic innervation and adrenocortical function. Diagnosis is often delayed until late adolescence or early adulthood, when patients display a markedly reduced ability to exercise. Diagnosis is made by the combination of minimal or undetectable plasma noradrenaline with a five-to tenfold elevation of dopamine. DBH deficiency, first described in the mid 1980s 4,5 would probably have been recognized earlier were it not for the fact that most medical centres tend to measure noradrenaline and adrenaline but not dopamine in the evaluation of autonomic dysfunction. Whilst there have been many papers describing anaesthetic and peripartum management of patients with dysautonomia of other aetiologies [6] [7] [8] [9] , this is the first report describing such management in a patient with DBH deficiency.
After reviewing the limited available literature on DBH deficiency and anaesthetic management of pregnant patients with autonomic dysfunction, we identified a number of key areas for concern.
Firstly, due to an attenuated sympathetic nervous system the patient was likely to be intolerant of blood loss and hypovolaemia. Her presentation was complicated further by the presence of a high-grade placenta praevia. Accordingly, crossmatched blood was made constantly available and the obstetric team educated regarding the need for early and aggressive fluid resuscitation in the event of an antepartum haemorrhage.
Secondly, due to low circulating catecholamines the patient would be likely to have significant upregulation of adrenergic receptors and display supersensitivity to exogenously administered adrenergic agonists 1, 10 . This had obvious implications for the use of vasoactive drugs in which case direct acting vasopressors are preferred 11 . We established specific protocols for the dilution of noradrenaline allowing for, through serial dilutions, 1,000-fold increased sensitivity to catecholamines. The expected upregulation of adrenergic receptors also demanded that adrenaline be excluded from any local anaesthetic mixture intended for either neuraxial or subcutaneous injection and also that oxytocics such as oxytocin, ergometrine and PGF2-α be used with due caution and in suitable dilutions. Ergometrine, in particular, could be expected to have an exaggerated hypertensive effect.
Thirdly, choice of anaesthetic technique for management of planned caesarean section also demanded special consideration. In addition to the areas already considered, the myopathic features associated with DBH deficiency raised concerns about the safety of using suxamethonium and volatile anaesthetic agents for general anaesthesia. Also, as has been well demonstrated in other patients with autonomic dysfunction, positive pressure ventilation could be expected to exacerbate hypotension post-induction. With respect to the former, details of a previous anaesthetic had shown uncomplicated exposure to suxamethonium and enflurane for a dental extraction at the age of 13. We expected to counter the latter by having the patient's legs in adjustable Allen's stirrups to allow rapid elevation in the event of hypotension associated with positive pressure ventilation. Due to the presence of an already effective sympathectomy and the patient's request to be awake for the operative delivery, our plan for the elective caesarean section was for a regional anaesthetic using a combined spinal-epidural technique.
Aware of these concerns we took extensive pre-cautions in preparing our patient for caesarean section. Fortunately, our precautionary efforts were not required and the patient's blood pressure was higher in the operating room than it had been during pregnancy. This appeared to demonstrate the effectiveness of DOPS in providing substrate for noradrenaline production. This case, although rare and unusual, provides stimulus and thought toward the management of the pregnant patient with dysautonomia. In particular it describes the successful and uncomplicated anaesthetic management of a patient for caesarean section with DBH deficiency and high-grade placenta praevia.
